Novartis | NOVN - Current Liabilities

Stock Price
126.46
Daily Change
-0.02 -0.02%
Monthly
10.60%
Yearly
28.84%
Q1 Forecast
123.39

Novartis reported $32B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Alcon AG USD 2.99B 566M Sep/2025
Almirall EUR 298.52M 54.91M Jun/2025
Amgen USD 25.49B 3.7B Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Autolus Therapeutics Ltd USD 83.07M 14.92M Sep/2025
Bayer EUR 28.96B 825M Sep/2025
Biogen USD 3.35B 59.4M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Fresenius Medical Care EUR 5.76B 98.85M Sep/2025
Galapagos EUR 366.56M 36.39M Sep/2025
Genmab DKK 629M 127M Jun/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GRIFOLS EUR 2.15B 164.7M Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
J&J USD 54.13B 3.26B Dec/2025
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 8.64B 1.22B Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 32B 286M Sep/2025
Novartis USD 32B 286M Sep/2025
Novo Nordisk DKK 215.66B 18.7B Dec/2025
Orion EUR 560.3M 9.8M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Philips EUR 7.51B 479M Dec/2025
Recordati EUR 1.04B 24.44M Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
UCB EUR 3.53B 731M Dec/2024